NCT03073863 Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study Status COMPLETED Phase PHASE4
NCT03073109 Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions Status COMPLETED Phase N/A
NCT03070548 A Study of Talazoparib in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03066427 Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment. Status COMPLETED Phase PHASE2
NCT03065062 Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors Status SUSPENDED Phase PHASE1
NCT03061201 A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A Status COMPLETED Phase PHASE2
NCT03059940 Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT03054363 Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03052608 A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03050554 SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC) Status TERMINATED Phase PHASE1/PHASE2
NCT03047980 Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome Status COMPLETED Phase PHASE2/PHASE3
NCT03046953 Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma Status COMPLETED Phase PHASE2
NCT03042910 A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03041792 Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects Status COMPLETED Phase PHASE1
NCT03038594 Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients Status COMPLETED Phase PHASE2/PHASE3
NCT03036813 Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE) Status COMPLETED Phase PHASE3
NCT03035630 Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma Status WITHDRAWN Phase PHASE2
NCT03034044 Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe Status COMPLETED Phase N/A